LSA
EW icon

Leonteq Securities AG’s Edwards Lifesciences EW Stock Holding History

Leonteq Securities AG’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.7K Sell
549
-1,340
-71% -$112K ﹤0.01% 805
2026
Q1 		$151K Buy
1,889
+1,142
+153% +$94.2K 0.01% 648
2025
Q4 		$63.7K Sell
747
-183
-20% -$15K ﹤0.01% 908
2025
Q3 		$72.3K Buy
930
+30
+3% +$2.34K ﹤0.01% 820
2025
Q2 		$70.4K Sell
900
-2,012
-69% -$150K ﹤0.01% 785
2025
Q1 		$211K Sell
2,912
-3,190
-52% -$228K 0.01% 534
2024
Q4 		$452K Sell
6,102
-32,540
-84% -$2.28M 0.03% 377
2024
Q3 		$2.55M Buy
38,642
+16,694
+76% +$1.21M 0.19% 110
2024
Q2 		$2.03M Sell
21,948
-25
-0.1% -$2.21K 0.14% 132
2024
Q1 		$2.1M Sell
21,973
-7,714
-26% -$648K 0.16% 148
2023
Q4 		$2.26M Sell
29,687
-3,245
-10% -$226K 0.13% 149
2023
Q3 		$2.28M Buy
32,932
+10,480
+47% +$842K 0.13% 164
2023
Q2 		$2.12M Sell
22,452
-6,795
-23% -$591K 0.11% 188
2023
Q1 		$2.42M Sell
29,247
-8,956
-23% -$704K 0.11% 166
2022
Q4 		$2.85M Buy
38,203
+10,453
+38% +$806K 0.11% 149
2022
Q3 		$2.29M Buy
27,750
+2,881
+12% +$277K 0.09% 169
2022
Q2 		$2.36M Buy
24,869
+2,962
+14% +$307K 0.09% 180
2022
Q1 		$2.58M Buy
21,907
+310
+1% +$34.8K 0.09% 170
2021
Q4 		$2.8M Buy
21,597
+1,288
+6% +$150K 0.1% 173
2021
Q3 		$2.3M Sell
20,309
-233
-1% -$26.6K 0.1% 179
2021
Q2 		$2.13M Sell
20,542
-1,667
-8% -$157K 0.13% 150
2021
Q1 		$1.86M Sell
22,209
-871
-4% -$73.6K 0.11% 161
2020
Q4 		$2.11M Buy
+23,080
New +$1.91M 0.11% 156

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Leonteq Securities AG's EW Position: Q2 2026 in Review

Leonteq Securities AG reduced its Edwards Lifesciences (EW) stake by 71% in Q2 2026, selling an estimated $112K and leaving 549 shares worth $49.7K. The position accounts for ﹤0.01% of the portfolio, ranked #805.

Leonteq Securities AG first reported a position in EW in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.85M in Q4 2022. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Leonteq Securities AG held 549 shares of Edwards Lifesciences worth $49.7K as of Q2 2026.
  • Leonteq Securities AG sold 1,340 Edwards Lifesciences shares in Q2 2026, an estimated $112K.
  • Edwards Lifesciences made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #805 holding.
  • Leonteq Securities AG first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 23 quarters since.
  • Leonteq Securities AG's Edwards Lifesciences position peaked at $2.85M in Q4 2022.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.